Global Cardiology Science and PracticeCell BiologyPeer-reviewed journal article
Generation of Valvular Interstitial Cells from Human Pluripotent Stem Cells
Amine MazineiD, Alexander A. MikryukoviD, Ian Fernandes, Clifford Z. LiuiD, Soheil JahangiriiD, Marcy MartiniD, Eric K. N. Gähwiler, Melanie GeneraliiD, Juliana Gomez, Neda LatifiiD, Yifei MiaoiD, Yu LiuiD, Michael A LaflammeiD, Craig A. SimmonsiD, Simon Philipp HoerstrupiD, Maximilian Y. EmmertiD, Bruce D. GelbiD, Mingxia GuiD, Gordon M. KelleriD
Abstract
Heart valves are living structures whose sophisticated functions are mediated by a specialized population of mesenchymal cells known as valvular interstitial cells (VICs). Given their central role in valve homeostasis, VICs represent a promising cell population for studying heart valve diseases and developing novel therapies to treat them. Here, we describe a strategy for generating VICs from human pluripotent stem cells (hPSCs) by stage-specific manipulation of developmental signalling pathways. Our results demonstrate that hPSC-derived VICs show a high transcriptional similarity to primary human fetal VICs and can secrete key proteins of the valve extracellular matrix. We further investigate the heterogeneity of hPSC-derived VICs and identify two major subpopulations with distinct molecular and functional properties, mirroring the cellular diversity observed in vivo. Finally, we utilize an in vitro model of Noonan syndrome to demonstrate that hPSC-derived VICs can accurately recapitulate key aspects of valve disease. Collectively, these findings provide a reproducible method for the scaled generation of bona fide hPSC-derived VICs and establish their utility in disease modelling and tissue engineering applications. Clinical PerspectiveO_ST_ABSWhat is new?C_ST_ABS- We established a robust platform to generate bona fide valvular interstitial cells (VICs) from human pluripotent stem cells (hPSCs), recapitulating native VIC identity and function. - We delineated signaling pathways that promote the development of two distinct VIC subsets and identified a surface marker to distinguish between them. What are the clinical implications?- A renewable, human-specific source of VICs enables precise mechanistic studies of valve development and disease that are not possible with limited surgical specimens or animal models. - This platform creates opportunities for therapeutic applications, including drug discovery and tissue engineering approaches for valve repair.
- organism: human
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 1
- FWCI
- 0.30
- Field percentile
- top 49%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Feeder-Free Generation of Endocardial and Cardiac Valve Cells from Human Pluripotent Stem Cells
C. Z. Liu, A. Prasad, … B. D. Gelb·bioRxiv·Mar 3, 2023
- A human cell model of cardiac pathophysiological valvulogenesis
Tui Néri, Emilye Hiriart, … Michel Pucéat·bioRxiv·Aug 22, 2018
- Generation of cardiac valve endocardial like cells from human pluripotent stem cells
Linxi Cheng, Minghui Xie, … Yuhua Sun·Communications BiologyPeer-reviewed·Sep 6, 2021
- Neural Crest-Derived Endocardial Cells Required for Heart Valve Development
Alexander F. Merriman, Mauro W. Costa, … Deepak Srivastava·bioRxiv·Nov 4, 2026
- Porcine and human aortic valve endothelial and interstitial cell isolation and characterization
D. Nehl, P. R. Goody, … M. R. Hosen·bioRxiv·Dec 1, 2022
- Generation of functional vasculature from engraftable human pluripotent stem cell-derived progenitors
Ian M. Fernandes, Hao Yin, … Gordon M. Keller·bioRxiv·May 15, 2026